MLICM
NAUT icon

Metropolitan Life Insurance Company (MetLife)’s Nautilus Biotechnolgy NAUT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-803
Closed -$2.4K – 2332
2023
Q4 		$2.4K Sell
803
-2,326
-74% -$6.66K ﹤0.01% 2313
2023
Q3 		$9.89K Hold
3,129
– – ﹤0.01% 2216
2023
Q2 		$12.1K Buy
+3,129
New +$9.01K ﹤0.01% 2199

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s NAUT Position: Q1 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Nautilus Biotechnolgy (NAUT) in Q1 2024, closing a stake of 803 shares — an estimated $2.4K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in NAUT in Q2 2023 and held it in 3 quarters. The position peaked at $12.1K in Q2 2023. 73 funds tracked by Wall St. Rank hold NAUT as of Q1 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Nautilus Biotechnolgy position as of Q1 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 803 Nautilus Biotechnolgy shares in Q1 2024, an estimated $2.4K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Nautilus Biotechnolgy in Q2 2023 and held it in 3 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Nautilus Biotechnolgy position peaked at $12.1K in Q2 2023.
  • 73 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2024, filed 14 May 2024.